Search results for "Pneumonia"
New antibiotic approved for hospital-acquired pneumonia
The FDA approved sulbactam and durlobactam for injection to treat hospital-acquired or ventilator-associated pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/07/05/new-antibiotic-approved-for-hospital-acquired-pneumonia.htm
5 Jul 2023
Procalcitonin do's and don'ts
Although the optimal use of procalcitonin is still up for debate, there are best practices for getting the most bang for this blood test.
https://acphospitalist.acponline.org/archives/2023/07/05/free/procalcitonin-dos-and-donts.htm
5 Jul 2023
Thinking about how you treat
The new field of management reasoning holds potential to improve medical education and practice, researchers say.
https://acphospitalist.acponline.org/archives/2023/06/21/thinking-about-how-you-treat.htm
21 Jun 2023
Adding up adverse events
Patient safety experts talk about the latest data and what hospitalists can do to improve them.
https://acphospitalist.acponline.org/archives/2023/06/07/adding-up-adverse-events.htm
7 Jun 2023
Replace diagnostic errors with excellence
Five strategies can help hospitalists achieve diagnostic excellence, a researcher says.
https://acphospitalist.acponline.org/archives/2023/05/24/free/replace-diagnostic-errors-with-excellence.htm
24 May 2023
Less definitely more in antibiotics
Review some common inpatient conditions that can be safely treated with shorter durations of antibiotics, reducing adverse events and costs.
https://acphospitalist.acponline.org/archives/2023/05/17/less-definitely-more-in-antibiotics.htm
17 May 2023
No benefit found from high-dose steroids, RAS inhibitors in latest COVID-19 trials
Multiple new studies tested renin-angiotensin system (RAS) inhibitors in inpatients with COVID-19, while the latest report from the RECOVERY trial found higher mortality in patients on no or regular oxygen who received high-dose corticosteroids compared to usual care.
https://acphospitalist.acponline.org/archives/2023/04/19/free/no-benefit-found-from-high-dose-steroids-ras-inhibitors-in-latest-covid-19-trials.htm
19 Apr 2023
Few low-risk inpatients with CAP switched from IV to oral therapy
Patients hospitalized with community-acquired pneumonia (CAP) who transitioned from IV to oral antibiotics by day 3 had shorter length of stay and lower hospitalization cost than those who did not, with no increase in 14-day mortality or ICU admission, a retrospective study found.
https://acphospitalist.acponline.org/archives/2023/04/12/few-low-risk-inpatients-with-cap-switched-from-iv-to-oral-therapy.htm
12 Apr 2023
Hospital rankings change when Medicare Advantage patients included
When researchers included both Medicare fee-for-service and Medicare Advantage beneficiaries in calculations of CMS performance measures, between 21.6% and 30.2% of hospitals in the top-performing group for readmissions and mortality fell to a lower-performing group.
https://acphospitalist.acponline.org/archives/2023/03/29/hospital-rankings-change-when-medicare-advantage-patients-included.htm
29 Mar 2023
Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19
Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
https://acphospitalist.acponline.org/archives/2023/03/29/free/higher-dose-prophylactic-anticoagulation-needed-to-prevent-thrombosis-in-hypoxemic-covid-19.htm
29 Mar 2023